Department of Health and Human Services October 14, 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 8 of 8
Announcement of the First Meeting of the 2010 Dietary Guidelines Advisory Committee and Solicitation of Written Comments
The Department of Agriculture and the Department of Health and Human Services (a) provide notice of the first meeting of the Dietary Guidelines Advisory Committee and (b) solicit written comments pertinent to review of the Dietary Guidelines for Americans.
Implementing the Patient Safety and Quality Improvement Act of 2005 Including How to Become a Patient Safety Organization: Interim Guidance Availability
AHRQ and OCR are announcing the availability of the guidance entitled ``Implementing the Patient Safety and Quality Improvement Act of 2005 Including How to Become a Patient Safety Organization.'' The Interim Guidance document explains how the Department of Health and Human Services (HHS) will begin implementing the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), how an entity can become a Patient Safety Organization (PSO), and how information may be protected as Patient Safety Work Product (PSWP) in the interim period prior to the promulgation of a final regulation. To access the Interim Guidance, visit AHRQ's PSO Web site at https://www.pso.ahrq.gov.
International Drug Scheduling; Convention of Psychotropic Substances; Single Convention on Narcotic Drugs; Gamma-hydroxybutyric acid; Ketamine; Dextromethorphan; N-benzylpiperazine; 1-(3-trifluoromethylphenyl) piperazine; 1-(3-chlorophenyl) piperazine; 1-(4-Methoxyphenyl) piperazine; 1-(3,4-methylenedioxybenzyl) piperazine; Gamma-butyrolactone; 1,4-Butanediol; Reopening of Comment Period
The Food and Drug Administration (FDA) is reopening until October 20, 2008, the comment period for the notice on ``International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs,'' published in the Federal Register of September 5, 2008 (73 FR 51823), requesting comments on abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 10 drug substances. FDA is taking this action in response to a request for a reopening of the comment period to allow interested persons additional time to review the notice and submit comments.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.